TCF7L2 Variant Rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action

Diabetes - United States
doi 10.2337/db09-1169
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

TCF 7l2 Gene Variant Rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Secretion

International Journal of Clinical Chemistry and Laboratory Medicine
2019English

Response Letter to Comment On: Villareal Et Al. (2009) TCF7L2 Variant Rs7903146 Affects the Risk of Type 2 Diabetes by Modulating Incretin Action. Diabetes; 59:479-485

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Genetic Variation in TCF7L2 Rs7903146 Correlating With Peripheral Arterial Disease in Long-Standing Type 2 Diabetes

Diabetes and Vascular Disease Research
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2019English

Transcription Factor 7-Like 2 (TCF7L2) Rs7903146 Polymorphism as a Risk Factor for Gestational Diabetes Mellitus: A Meta-Analysis

PLoS ONE
Multidisciplinary
2016English

Common Coding Variant in the TCF7L2 Gene and Study of the Association With Type 2 Diabetes in Japanese Subjects

Journal of Human Genetics
Genetics
2008English

Association of Rs7903146 (IVS3C/T) and Rs290487 (IVS3C/T) Polymorphisms in TCF7L2 With Type 2 Diabetes in 9,619 Han Chinese Population

PLoS ONE
Multidisciplinary
2013English

Which Incretin-Based Therapy for Type 2 Diabetes?

The Lancet
Medicine
2014English

Meta-Analysis of Associations Between TCF7L2 Polymorphisms and Risk of Type 2 Diabetes Mellitus in the Chinese Population

BMC Medical Genetics
Genetics
2013English

Erratum: Incretin Mimetics Vie for Slice of Type 2 Diabetes Market

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy